NO20062491L - Benzoksazinderivter og deres anvendelse - Google Patents
Benzoksazinderivter og deres anvendelseInfo
- Publication number
- NO20062491L NO20062491L NO20062491A NO20062491A NO20062491L NO 20062491 L NO20062491 L NO 20062491L NO 20062491 A NO20062491 A NO 20062491A NO 20062491 A NO20062491 A NO 20062491A NO 20062491 L NO20062491 L NO 20062491L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- benzoxazine derivatives
- formula
- benzoxazine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52837803P | 2003-12-09 | 2003-12-09 | |
| PCT/EP2004/013557 WO2005058847A1 (en) | 2003-12-09 | 2004-11-30 | Benzoxazine derivatives and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20062491L true NO20062491L (no) | 2006-09-06 |
Family
ID=34699863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20062491A NO20062491L (no) | 2003-12-09 | 2006-05-31 | Benzoksazinderivter og deres anvendelse |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7202241B2 (pt) |
| EP (1) | EP1694656B1 (pt) |
| JP (1) | JP4527730B2 (pt) |
| KR (1) | KR100827915B1 (pt) |
| CN (1) | CN100532369C (pt) |
| AR (1) | AR046753A1 (pt) |
| AT (1) | ATE371653T1 (pt) |
| AU (1) | AU2004299201B2 (pt) |
| BR (1) | BRPI0416873A (pt) |
| CA (1) | CA2547764A1 (pt) |
| CO (1) | CO5700768A2 (pt) |
| DE (1) | DE602004008668T2 (pt) |
| ES (1) | ES2291984T3 (pt) |
| IL (1) | IL175817A0 (pt) |
| MY (1) | MY145576A (pt) |
| NO (1) | NO20062491L (pt) |
| NZ (1) | NZ547120A (pt) |
| RU (1) | RU2354651C2 (pt) |
| TW (1) | TW200522953A (pt) |
| WO (1) | WO2005058847A1 (pt) |
| ZA (1) | ZA200604725B (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1408976B3 (en) | 2001-07-20 | 2010-08-25 | Psychogenics Inc. | Treatment for attention-deficit hyperactivity disorder |
| US7713954B2 (en) * | 2004-09-30 | 2010-05-11 | Roche Palo Alto Llc | Compositions and methods for treating cognitive disorders |
| CA2582273C (en) * | 2004-09-30 | 2013-10-29 | Douglas William Bonhaus | Compositions and methods for treating cognitive disorders using serotonin receptor antagonists |
| CN101448803A (zh) * | 2006-03-17 | 2009-06-03 | 阿斯利康(瑞典)有限公司 | 用作5-ht6调节剂的四氢萘 |
| CL2007003044A1 (es) * | 2006-10-24 | 2008-07-04 | Wyeth Corp | Compuestos derivados de benzoxazina; composicion farmaceutica que los comprende; y uso para el tratamiento de un trastorno psicotico, bipolar, depresivo y abuso o dependencia de sustancias entre otros. |
| WO2011023753A1 (en) * | 2009-08-27 | 2011-03-03 | Glaxo Group Limited | Benzoxazine derivatives as glycine transport inhibitors |
| CN101836993B (zh) | 2010-05-20 | 2011-06-22 | 山东大学 | 2，3-二氢-3-羟甲基-6-氨基-[1，4]-苯并噁嗪在制备诱导胚胎干细胞向血管内皮细胞分化药物中的应用 |
| CN102060810B (zh) * | 2010-12-20 | 2012-07-04 | 金坛市爱特生物科技有限公司 | 一种n-叔丁氧羰基-哌嗪的提纯方法 |
| JP2017507950A (ja) | 2014-02-27 | 2017-03-23 | リセラ・コーポレイションＬｙｃｅｒａ Ｃｏｒｐｏｒａｔｉｏｎ | レチノイン酸受容体関連オーファン受容体ガンマのアゴニストを使用する養子細胞療法及び関連治療方法 |
| JP6728061B2 (ja) | 2014-05-05 | 2020-07-22 | リセラ・コーポレイションＬｙｃｅｒａ Ｃｏｒｐｏｒａｔｉｏｎ | ＲＯＲγアゴニストとして用いるテトラヒドロキノリンスルホンアミド及び関連化合物ならびに疾患の治療 |
| WO2015171558A2 (en) | 2014-05-05 | 2015-11-12 | Lycera Corporation | BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE |
| SG11201610407QA (en) | 2014-07-08 | 2017-01-27 | Sunshine Lake Pharma Co Ltd | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
| EP3292119A4 (en) | 2015-05-05 | 2018-10-03 | Lycera Corporation | DIHYDRO-2H-BENZO[b][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE |
| US10611740B2 (en) * | 2015-06-11 | 2020-04-07 | Lycera Corporation | Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease |
| CN109568321B (zh) * | 2019-01-14 | 2022-02-22 | 山东轩竹医药科技有限公司 | RORγ调节剂 |
| KR20230050369A (ko) * | 2020-08-07 | 2023-04-14 | 카스마 테라퓨틱스, 인코포레이티드 | Trpml 조절제 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8803419D0 (en) * | 1988-02-15 | 1988-03-16 | Erba Carlo Spa | 1 4-benzoxazine & 1 4-benzothiazine derivatives & process for their preparation |
| GB9507203D0 (en) | 1995-04-07 | 1995-05-31 | Smithkline Beecham Plc | Novel compounds |
| BR9809092A (pt) | 1997-04-18 | 2002-01-22 | Smithkline Beecham Plc | Derivados de indol tendo atividade combinada de antagonista de receptor de 5ht1a, 5ht1b e 5ht1d |
| US6380235B1 (en) | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Benzimidazolones and analogues |
| US6566372B1 (en) | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
| EP1255743A1 (en) | 2000-02-01 | 2002-11-13 | Millenium Pharmaceuticals, Inc. | 3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE INHIBITORS OF FACTOR Xa |
| ATE316523T1 (de) * | 2002-05-13 | 2006-02-15 | Hoffmann La Roche | Benzoxazinderivate als 5-ht6-modulatoren und deren verwendungen |
| CN100390157C (zh) * | 2002-11-08 | 2008-05-28 | 弗·哈夫曼-拉罗切有限公司 | 取代的苯并嗪酮及其用途 |
-
2004
- 2004-11-30 CA CA002547764A patent/CA2547764A1/en not_active Abandoned
- 2004-11-30 AU AU2004299201A patent/AU2004299201B2/en not_active Ceased
- 2004-11-30 EP EP04820410A patent/EP1694656B1/en active Active
- 2004-11-30 JP JP2006543432A patent/JP4527730B2/ja not_active Expired - Fee Related
- 2004-11-30 NZ NZ547120A patent/NZ547120A/en unknown
- 2004-11-30 DE DE602004008668T patent/DE602004008668T2/de active Active
- 2004-11-30 CN CNB2004800368183A patent/CN100532369C/zh not_active Expired - Fee Related
- 2004-11-30 KR KR1020067011286A patent/KR100827915B1/ko not_active IP Right Cessation
- 2004-11-30 AT AT04820410T patent/ATE371653T1/de active
- 2004-11-30 WO PCT/EP2004/013557 patent/WO2005058847A1/en active IP Right Grant
- 2004-11-30 ES ES04820410T patent/ES2291984T3/es active Active
- 2004-11-30 BR BRPI0416873-9A patent/BRPI0416873A/pt not_active Application Discontinuation
- 2004-11-30 RU RU2006124513/04A patent/RU2354651C2/ru not_active IP Right Cessation
- 2004-12-07 AR ARP040104555A patent/AR046753A1/es not_active Application Discontinuation
- 2004-12-07 MY MYPI20045047A patent/MY145576A/en unknown
- 2004-12-08 TW TW093137995A patent/TW200522953A/zh unknown
- 2004-12-09 US US11/008,310 patent/US7202241B2/en not_active Expired - Fee Related
-
2006
- 2006-05-22 IL IL175817A patent/IL175817A0/en unknown
- 2006-05-31 NO NO20062491A patent/NO20062491L/no not_active Application Discontinuation
- 2006-06-08 ZA ZA200604725A patent/ZA200604725B/xx unknown
- 2006-06-12 CO CO06056964A patent/CO5700768A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2291984T3 (es) | 2008-03-01 |
| IL175817A0 (en) | 2006-10-05 |
| AR046753A1 (es) | 2005-12-21 |
| KR100827915B1 (ko) | 2008-05-07 |
| DE602004008668D1 (de) | 2007-10-11 |
| CN100532369C (zh) | 2009-08-26 |
| CA2547764A1 (en) | 2005-06-30 |
| ZA200604725B (en) | 2007-12-27 |
| US7202241B2 (en) | 2007-04-10 |
| EP1694656B1 (en) | 2007-08-29 |
| CO5700768A2 (es) | 2006-11-30 |
| AU2004299201B2 (en) | 2009-12-03 |
| RU2354651C2 (ru) | 2009-05-10 |
| KR20060097758A (ko) | 2006-09-15 |
| BRPI0416873A (pt) | 2007-02-27 |
| MY145576A (en) | 2012-02-29 |
| AU2004299201A1 (en) | 2005-06-30 |
| EP1694656A1 (en) | 2006-08-30 |
| WO2005058847A1 (en) | 2005-06-30 |
| TW200522953A (en) | 2005-07-16 |
| JP4527730B2 (ja) | 2010-08-18 |
| JP2007513904A (ja) | 2007-05-31 |
| CN1890227A (zh) | 2007-01-03 |
| RU2006124513A (ru) | 2008-01-27 |
| US20050124613A1 (en) | 2005-06-09 |
| DE602004008668T2 (de) | 2008-06-12 |
| NZ547120A (en) | 2009-02-28 |
| ATE371653T1 (de) | 2007-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062491L (no) | Benzoksazinderivter og deres anvendelse | |
| NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
| NO20091893L (no) | Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav. | |
| NO20066055L (no) | Pyridinderivater | |
| NO20060147L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| NO20054135L (no) | Kipolinon/benzoksazin derivater og anvendelser derav | |
| NO20080789L (no) | 1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid | |
| NO20061839L (no) | Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav | |
| NO20050666L (no) | 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer | |
| NO20072689L (no) | Tetrasykliske indolderivater som antivirale midler | |
| NO20050828L (no) | lndol-3-svovelderivater | |
| NO20055977L (no) | Nye benzimidazolderivater | |
| NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
| NO20072978L (no) | Nye betuinderivater, preparat derav og anvendelse derav | |
| NO20065060L (no) | Farmasoytiske kombinasjoner inneholdende benzoksazin for behandling av respiratoriske forstyrrelser | |
| NO20045486L (no) | Nye forbindelser og deres anvendelse | |
| NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| NO20050088L (no) | Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav | |
| NO20065880L (no) | 3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor | |
| NO20052730L (no) | Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser | |
| NO20081844L (no) | Terapeutiske forbindelser | |
| NO20040881L (no) | Orale antidiabetes midler. | |
| NO20080110L (no) | Benzimidazolderivativer som 5-HT6,5-HT24 | |
| NO20065030L (no) | Aerosolformulering for inhalering av beta agonister. | |
| NO20072089L (no) | Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |